RECRUITING

The Biosonographic Index

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

In this exploratory study we explore the use of Shear Wave Elastography to differentiate between Acute Kidney Injury after vascular surgery and among the healthy population.

Official Title

The Biosonographic Index - A Novel Index for the Early Detection of Acute Kidney Injury After Vascular Surgery - an Exploratory Study.

Quick Facts

Study Start:2020-01-15
Study Completion:2026-12-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04144894

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:19 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * No history of diabetes or hypertension
  2. * Estimated Glomerular Filtration Rate \> 60 ml/min/m\^2
  3. * Structurally normal kidney on renal ultrasound
  4. * BMI \< 27 kg/m\^2
  1. * Prisoners directly admitted from a correctional facility
  2. * Children \< 19 years or under 50 kg body weight if age is unknown
  3. * Patients with end stage renal disease or preexisting glomerular filtration rate less than or equal to 30 mL/min/1.73 m\^2 or need for dialysis
  4. * Patients with end stage heart disease on the cardiac transplant list
  5. * Patients undergoing procedures without vascular surgery
  6. * All transplant patients
  7. * Patients on ventricular assist devices
  8. * Patients undergoing emergency procedures
  9. * Patients with body mass index \> 27kg/m\^2
  10. * Any condition that would impede visualization of the kidneys by ultrasound

Contacts and Locations

Study Contact

Adam B Sturdivant, MPH
CONTACT
205-934-4042
Adamsturdivant@uabmc.edu
Ayesha Bryant, MD, MSPH
CONTACT
205-996-7383
Asbryant@uabmc.edu

Principal Investigator

Ahmed Zaky, MD, MPH
PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham

Study Locations (Sites)

University of Alabama at Birmingham
Birmingham, Alabama, 35249
United States

Collaborators and Investigators

Sponsor: University of Alabama at Birmingham

  • Ahmed Zaky, MD, MPH, PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-01-15
Study Completion Date2026-12-02

Study Record Updates

Study Start Date2020-01-15
Study Completion Date2026-12-02

Terms related to this study

Additional Relevant MeSH Terms

  • Acute Kidney Injury